SCHEMBL20710342

SCHEMBL20710342

c1ccc(-c2cc(-c3ccc4c(c3)-c3ccccc3C43c4ccccc4-c4ccccc43)cc(N(c3ccccc3)c3ccc4c(c3)C(c3ccccc3)(c3ccccc3)c3ccccc3-4)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
OPRK1 P41145 1/20 0.35
PDK2 Q15119 3/20 0.35
APAF1 O14727 1/20 0.32
NPC1 O15118 1/20 0.32
THRB P10828 1/20 0.32
XBP1 P17861 1/20 0.32
PTBP1 P26599 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
GALK1 P51570 1/20 0.32
BLM P54132 1/20 0.32
SMAD3 P84022 1/20 0.32
ATM Q13315 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17854512 0.94 MAPT (0.38) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL17854518 0.94 MAPT (0.38) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL17854510 0.94 MEN1 (0.40) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL26574479 0.93 MEN1 (0.35) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL17854596 0.93 PDK2 (0.39) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL19954081 0.93 PDK2 (0.39) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21559418 0.93 KDM4E (0.36) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21392613 0.93 PDK2 (0.38) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL17854382 0.93 KDM4E (0.39) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21923950 0.93 MEN1 (0.39) MEN1LMNAMAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190040034-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190040034-A1 MATERIALS FOR ELECTRONIC DEVICES EFNA1, GPX1, EPX MEN1 306/4885LMNA 2383/4885MAPT 3100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.